Taxus wallichiana Zucc. (Himalayan Yew): A Medicinal Plant Exhibiting Antibacterial Properties.

Taxus wallichiana Zucc. or the Himalayan yew is a gymnosperm growing along the Himalayan region of India and adjacent countries. Traditionally, this plant was extensively used by indigenous people for folk medicines for treating various diseases such as fever, headache, diarrhoea, fractures, problems of the nervous system etc. It is also practiced in the Unani system of medicine. The plant is rich in various bio-organic compounds and natural products, such as hydrocarbons, glycosides, flavonoids, phenol, tannins, terpenoids etc. In this research work, an effort has been made to highlight the valuable properties of T. wallichiana. The present study was undertaken to evaluate the secondary metabolites (flavonoids, glycosides, phenols, saponins, tannins, terpenoids) and antibacterial potential of methanol extracts and the subsequent fractions of the leaves and fruit of Taxus wallichiana Zucc. In order to rationalise traditional use, methanol extracts from the leaves and fruit of Taxus wallichiana Zucc. were tested against five bacteria using the agar well diffusion method. Ciprofloxacin was used as a standard. All extracts and fractions displayed significant anti-microbial effects. Taxus wallichiana leaves and fruit methanolic extracts showed a maximum zone of inhibition with Bacillus subtilis, which is 18 ± 0.0 mm, and Staphylococcus aureus, 19 ± 0.2 mm. The methanolic extracts of the leaves of Taxus wallichiana tested positive for glycosides, flavonoids, phenol, tannins and terpenoids, whereas the T. wallichiana fruit tested positive for flavonoids, saponins and terpenoids. According to the research findings, it was identified that the methanol extract of Taxus wallichiana exhibited quite high anti-microbial activity as well as secondary metabolites, and with this quality, together with lots of its other values, this plant can very well become a source of medicine for the better management of a large number of diseases, including cancer, and value-added products.

Antimicrobial Potential of Cocos nucifera (Coconut) Oil on Bacterial Isolates.

This study investigates the in vitro antibacterial activity of coconut oil on selected clinical and pure bacterial isolates. Clinical samples were isolated from the people of Ras Al Khaimah, United Arab Emirates. Biochemical examination of the microorganisms was done according to standard methods. Pure bacterial cultures were provided from LTA srl Italia. In this research work, an effort has been made to highlight the valuable properties of Cocos nucifera oil, in order to rationalize the use of coconut oil against bacteria. Experiments were performed by agar well diffusion method. Ciprofloxacin was used as a standard antibiotic. The assay of antibacterial activity of clinical isolate of Streptococcus species showed the highest susceptibility to coconut oil while Escherichia coli had the least. This study endorses the use of coconut oil as therapeutic agent since it contains lauric acid which is bactericidal. The utilization of coconut oil should be promoted as a functional food and the use of coconut seed flesh in our diets should be encouraged for health-supporting functions. Further studies should be done on the oil and its derivatives both in vitro and in vivo to unveil their mechanism of action.

The chitinolytic activity of the Curtobacterium sp. isolated from field-grown soybean and analysis of its genome sequence.

Curtobacterium sp. GD1 was isolated from leaves of conventionally grown soybean in Brazil. It was noteworthy that among all bacteria previously isolated from the same origin, only Curtobacterium sp. GD1 showed a strong chitinase activity. The enzyme was secreted and its production was induced by the presence of colloidal chitin in the medium. The chitinase was partially purified and characterized: molecular weight was approximately 37 kDa and specific activity 90.8 U/mg. Furthermore, Curtobacterium sp. GD1 genome was sequenced and analyzed. Our isolate formed a phylogenetic cluster with four other Curtobacterium spp. strains, with ANIb/ANIm ≥ 98%, representing a new, still non described Curtobacterium species. The circular genome visualization and comparison of genome sequences of strains forming new cluster indicated that most regions within their genomes were highly conserved. The gene associated with chitinase production was identified and the distribution pattern of glycosyl hydrolases genes was assessed. Also, genes associated with catabolism of structural carbohydrates such as oligosaccharides, mixed polysaccharides, plant and animal polysaccharides, as well as genes or gene clusters associated with resistance to antibiotics, toxic compounds and auxin biosynthesis subsystem products were identified. The abundance of putative glycosyl hydrolases in the genome of Curtobacterium sp. GD1 suggests that it has the tools for the hydrolysis of different polysaccharides. Therefore, Curtobacterium sp. GD1 isolated from soybean might be a bioremediator, biocontrol agent, an elicitor of the plant defense responses or simply degrader.